Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

CV

+ Watchlist+ Portfolio

CapsoVision, Inc.

Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$6.82
52-Week Range
$4.50 – $15.37
Market Cap
$338.28M
P/E (TTM)
—
EPS (TTM)
-0.42
Dividend Yield
0.00%
Advanced Metrics
Price/Book
12.83
PEG Ratio
—
Return on Equity
-124.96%
Return on Assets
-62.40%
Gross Margin
49.70%
Operating Margin
-209.48%
Profit Margin
-210.09%
Current Ratio
5.07
Debt/Equity
0.03
Total Debt
$780.00K
Free Cash Flow
$-17.29M
Revenue Growth
0.80%
Earnings Growth
—
Enterprise Value
$344.64M

Market Snapshot

About

CapsoVision, Inc. is a medical device company specializing in capsule endoscopy technology for gastrointestinal diagnostics. Headquartered in Saratoga, California, the company manufactures and markets the CapsoCam Plus system, a wireless capsule camera that patients swallow to capture images of the small intestine. The device uses four cameras to provide 360-degree panoramic views, differentiating it from single-camera competitors. CapsoVision's technology is used by gastroenterologists to diagnose conditions such as Crohn's disease, gastrointestinal bleeding, and small bowel tumors.